Epidermal growth factor receptor mutations in non-small cell lung cancer: Predicting clinical response to kinase inhibitors

被引：19
|
作者：
Sequist, LV [1 ]
Haber, DA [1 ]
Lynch, TJ [1 ]
机构：
[1] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA
来源：
CLINICAL CANCER RESEARCH | 2005年 / 11卷 / 16期
关键词：
D O I：
10.1158/1078-0432.CCR-05-1055
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：5668 / 5670
页数：3
相关论文
共 50 条
  • [1] Epidermal growth factor receptor tyrosine kinase inhibitors for non-small cell lung cancer
    Asami, Kazuhiro
    Atagi, Shinji
    [J]. WORLD JOURNAL OF CLINICAL ONCOLOGY, 2014, 5 (04): : 646 - 659
  • [2] Clinical characteristics and response to tyrosine kinase inhibitors of patients with non-small cell lung cancer harboring uncommon epidermal growth factor receptor mutations
    Zhang, Yan
    Wang, Zheng
    Hao, Xuezhi
    Hu, Xingsheng
    Wang, Hongyu
    Wang, Yan
    Ying, Jianming
    [J]. CHINESE JOURNAL OF CANCER RESEARCH, 2017, 29 (01) : 18 - 24
  • [3] Clinical characteristics and response to tyrosine kinase inhibitors of patients with non-small cell lung cancer harboring uncommon epidermal growth factor receptor mutations
    Yan Zhang
    Zheng Wang
    Xuezhi Hao
    Xingsheng Hu
    Hongyu Wang
    Yan Wang
    Jianming Ying
    [J]. Chinese Journal of Cancer Research, 2017, 29 (01) : 18 - 24
  • [4] Epidermal growth factor receptor inhibitors in non-small cell lung cancer
    Dancey, Janet E.
    [J]. DRUGS, 2007, 67 (08) : 1125 - 1138
  • [5] Epidermal Growth Factor Receptor Inhibitors in Non-Small Cell Lung Cancer
    Janet E. Dancey
    [J]. Drugs, 2007, 67 : 1125 - 1138
  • [6] Mutations in the tyrosine kinase domain of the epidermal growth factor receptor in non-small cell lung cancer
    Yang, SH
    Mechanic, LE
    Yang, P
    Landi, MT
    Bowman, ED
    Wampfler, J
    Meerzaman, D
    Hong, KM
    Mann, F
    Dracheva, T
    Fukuoka, J
    Travis, W
    Caporaso, NE
    Harris, CC
    Jen, A
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (06) : 2106 - 2110
  • [7] Effectiveness of Tyrosine Kinase Inhibitors on "Uncommon" Epidermal Growth Factor Receptor Mutations of Unknown Clinical Significance in Non-Small Cell Lung Cancer
    Wu, Jenn-Yu
    Yu, Chong-Jen
    Chang, Yeun-Chung
    Yang, Chih-Hsin
    Shih, Jin-Yuan
    Yang, Pan-Chyr
    [J]. CLINICAL CANCER RESEARCH, 2011, 17 (11) : 3812 - 3821
  • [8] Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer
    Kujtan, Lara
    Subramanian, Janakiraman
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2019, 19 (07) : 547 - 559
  • [9] Resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer
    周清
    魏雪武
    高欣
    何韵婷
    杨潇蓉
    [J]. Science Foundation in China, 2019, 27 (01) : 72 - 80
  • [10] Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Advanced Non-Small Cell Lung Cancer
    Ogunleye, Foluso
    Ibrahim, Mohammed
    Stender, Michael
    Kalemkerian, Gregory
    Jaiyesimi, Ishmael
    [J]. AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2015, 11 (01) : 16 - 25
12345